Reversal of Dopamine D2Receptor Responses by an Anandamide Transport Inhibitor
Open Access
- 1 May 2000
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 20 (9), 3401-3407
- https://doi.org/10.1523/jneurosci.20-09-03401.2000
Abstract
We characterized the pharmacological properties of the anandamide transport inhibitorN-(4-hydroxyphenyl)-arachidonamide (AM404) in rats and investigated the effects of this drug on behavioral responses associated with activation of dopamine D2 family receptors. Rat brain slices accumulated [3H]anandamide via a high-affinity transport mechanism that was blocked by AM404. When administered alone in vivo, AM404 caused a mild and slow-developing hypokinesia that was significant 60 min after intracerebroventricular injection of the drug and was reversed by the CB1 cannabinoid receptor antagonist SR141716A. AM404 produced no significant catalepsy or analgesia, two typical effects of direct-acting cannabinoid agonists. However, AM404 prevented the stereotypic yawning produced by systemic administration of a low dose of apomorphine, an effect that was dose-dependent and blocked by SR141716A. Furthermore, AM404 reduced the stimulation of motor behaviors elicited by the selective D2family receptor agonist quinpirole. Finally, AM404 reduced hyperactivity in juvenile spontaneously hypertensive rats, a putative model of attention deficit hyperactivity disorder. The results support a primary role of the endocannabinoid system in the regulation of psychomotor activity and point to anandamide transport as a potential target for neuropsychiatric medicines.Keywords
This publication has 36 references indexed in Scilit:
- Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficitNeuroscience & Biobehavioral Reviews, 2000
- Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the ratNeuroReport, 1997
- Dopamine D2 Receptors in Signal Transduction and BehaviorCritical Reviews™ in Neurobiology, 1997
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strainsPhysiology & Behavior, 1993
- Dopaminergic Regulation of Cannabinoid Receptor mRNA Levels in the Rat Caudate‐Plitamen: An In Situ Hybridization StudyJournal of Neurochemistry, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76Neuropharmacology, 1989
- Interactions of Δ9-tetrahydrocannabinol with d-Amphetamine, cocaine, and nicotine in ratsPharmacology Biochemistry and Behavior, 1978